NCT05614700View on ClinicalTrials.gov

Prostate Reirradiation Toxicity Outcomes Feasibility Study

NANot yet recruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

November 15, 2022

Primary Completion Date

November 15, 2024

Study Completion Date

November 15, 2026

Conditions
Prostate CancerRadiotherapy Side Effect
Interventions
RADIATION

Brachytherapy

High Dose-Rate Brachytherapy

RADIATION

Sterotactic Body Radiotherapy

Hypofractionated External Beam Radiotherapy

All Listed Sponsors
lead

University of Leeds

OTHER

NCT05614700 - Prostate Reirradiation Toxicity Outcomes Feasibility Study | Biotech Hunter | Biotech Hunter